Cipla, the second largest Indian pharma company with sales of Rs 3114 crore, achieved impressive financial performance during the first quarter ended June 2006. Its net profit has taken a quantum jump of 53 per cent to Rs 170.43 crore from Rs 111.40 crore in the corresponding period of last year. The company's net sales for the quarter increased by 30.3 per cent to Rs 863.68 crore from Rs 700.91 crore.
The earning per share, after considering enhance paid-up capital resulted from the bonus issue, worked out to Rs 2.21 as compared to Rs 1.49. The paid-up capital increased to Rs 155.46 crore from Rs 59.97 crore after allotment of 110.46 lakh shares underlying Global Depository Receipts and bonus shares.
The company's other income increased by 163 per cent to Rs 21.95 crore from Rs 8.36 crore. The staff cost and depreciation provisions increased by 30.8 per cent and 92.6 per cent respectively to Rs 51.31 crore and Rs 26 crore.